About
Renslow Sherer, MD, is a Professor of Medicine in the Section of Infectious Diseases at the University of Chicago and serves as the Director of the International HIV Training Center. He has been a primary caregiver for people living with HIV since 1982, founding the first HIV clinic in Chicago at Cook County Hospital and co-founding the AIDS Foundation of Chicago. Dr. Sherer has contributed extensively to research on HIV prevention, care, model care programs, and medical education across the US, China, and Africa. He has served as the Director of the Wuhan Medical Education Reform Project in Wuhan, China, since 2009 and is an Emeritus Faculty member of Wuhan University Medical School. Additionally, he has directed an annual course on Health and Human Rights at the Pozen Family Center for Human Rights since 2013. His work includes numerous publications on the clinical and social impact of the HIV pandemic, emphasizing his long-standing commitment to advancing HIV care and education.
Research topics
- Computer Science
- Artificial Intelligence
- Surgery
- Medicine
- Intensive care medicine
- Nursing
- Internal medicine
- Pedagogy
- Mathematics education
- Family medicine
- Psychology
Selected publications
Sexual Health · 2026-01-09
articleBACKGROUND: Co-creation has the potential to generate people-centered mobile health (mHealth) interventions to improve PrEP adherence. This study generated people-centered mHealth messages with Chinese gay, bisexual and other men who have sex with men (GBMSM) via a structured co-creation approach, and evaluated the messages quality, and assessed the feasibility of the co-creation approach. METHODS: A three-step co-creation framework was implemented with 19 GBMSM PrEP users and six HIV researchers between 2021 and 2023. Messages were assessed via 10-point scales, and the degree of usefulness by co-creators and 783 participants from a PrEP demonstration trial. Thematic analysis identified PrEP adherence barriers and participants' reflections from meeting notes and materials, with descriptive statistics summarizing evaluation results. RESULTS: Four levels of PrEP adherence barriers were identified (insufficient education, efficacy concerns, inadequate behavioral skills, PrEP stigma). Based on these barriers, 25 mHealth messages (19 posters, three videos, three text messages) were co-created, covering nine themes (e.g. missed dose coping, side-effect management). Seventeen high-quality messages were selected, with mean scores of 8.25 (relevance), 7.86 (appropriateness) and 7.25 (elaboration). Among GBMSM PrEP users who received the messages, 90.4% (708/783) valued the co-created messages as helpful. Reflections from the co-creators highlighted the value of the participatory process, confirming that co-creation effectively engages GBMSM PrEP users. CONCLUSIONS: Co-creation groups are feasible for Chinese GBMSM to identify context-specific PrEP adherence barriers and develop people-centered mHealth messages, supporting the value of co-creation for PrEP adherence intervention development in this population.
SSRN Electronic Journal · 2026-01-01
preprintOpen accessUNC Libraries · 2026-02-11
articleOpen accessElsevier eBooks · 2025-01-01
book-chapterOpen accessTreating concomitant human immunodeficiency virus and monkeypox virus infection
Elsevier eBooks · 2025-01-01
book-chapterSexual Health · 2025-03-16 · 2 citations
articleOpen accessBackground Data on persistent use of HIV pre-exposure prophylaxis (PrEP) is limited among Chinese men who have sex with men (MSM). This study aimed to explore factors associated with the re-initiation of PrEP among Chinese MSM from a longitudinal PrEP demonstration trial. Methods A multi-center cohort study was conducted in Guangzhou and Wuhan, China (September 2021-2024), providing 1134 MSM participants with a 12-month dosage of tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) as oral PrEP. Following the trial, a subgroup of participants were invited to complete a 3-month post-trial follow-up survey. These participants were categorized on the basis of self-reported PrEP use patterns into (1) continued PrEP use, (2) discontinued without re-initiation, and (3) re-initiated after discontinuation. Log-binomial regression models were used to assess factors associated with PrEP re-initiation. Results Out of 408 participants who completed the 3-month post-trial follow-up survey, 70.1% (n =286/408) reported discontinuing PrEP, and 50.7% (n =145/286) of those who discontinued subsequently re-initiated PrEP. Participants who had concurrent sexual partnerships (adjusted risk ratio [aRR]=1.47, 95% CI: 1.11-1.96), used drugs during sex (aRR=1.34, 95% CI: 1.09-1.65), or lived alone (aRR=1.29, 95% CI: 1.03-1.61) were more likely to re-initiate PrEP. The Likert scale analysis indicated that perceived partner influence, specifically the expectation of condomless sex, played a significant role in re-initiation decisions (P =0.03). Conclusion Individuals engaging in higher-risk behaviors are more likely to re-initiate PrEP, highlighting the dynamic nature of risk perception. Future interventions should focus on promoting both re-initiation and consistent condom use, emphasizing partner-related dynamics and substance use as key factors in PrEP decisions among MSM.
Daily PrEP and event-driven PrEP adherence for men who have sex with men in China
Sexual Health · 2025-12-03
articleBACKGROUND: The HIV incidence among Chinese men who have sex with men (MSM) has still been high over the past decade. Despite HIV pre-exposure prophylaxis (PrEP) being an effective prevention strategy, few studies have examined PrEP uptake and adherence in China. This study examined PrEP initiation and adherence among Chinese MSM enrolled in a multi-site PrEP demonstration trial. METHODS: Three-month data for this study were drawn from a PrEP demonstration project in Guangzhou and Wuhan, China. The project aimed to increase the engagement of MSM in China for HIV/STI screening, HIV risk reduction, and PrEP initiation and adherence through the use of a mobile phone app and community engagement with crowdsourcing of messages and study images. Part of the intervention was the provision of tenofovir/emtricitabine as PrEP through two types of modalities: (1) once-daily oral dose (Daily-PrEP), or (2) event-driven dose (i.e. the 2 + 1 + 1 approach, Event-Driven PrEP). The outcome of interest was PrEP adherence, defined as missing fewer than five pills in the past 30 days for Daily PrEP, and no missed doses for the Event-Driven PrEP regimen. Univariate and multivariate logistic regressions were conducted for data analyses. RESULTS: A total of 927 individuals started PrEP, with follow-up data available for 650 people (70%) after 3 months. There were 593 men with a median age of 30 years (range 21-61 years) in this study. Of those people, 341 reported taking Daily-PrEP, and 93% (317/341) reported missing fewer than five pills in the past 30 days. Among 252 participants who reported taking the Event-Driven PrEP regimen, 61.5% (155/252) reported full adherence. Daily-PrEP users were more likely to report good adherence than Event-Driven PrEP users (OR 7.28, P < 0.0001, 95% CI: 4.28-12.39). CONCLUSION: We observed a higher adherence to daily PrEP compared with Event-Driven PrEP among a sample of MSM in China. Further research is needed to examine long-term PrEP adherence among MSM in China.
Impact of Peer Referral on Pre-Exposure Prophylaxis Adherence and Persistence Among Men Who Have Sex with Men: A Cohort Study in China
Open MIND · 2025-01-01
articleAIDS and Behavior · 2025-02-10 · 2 citations
articleUNC Libraries · 2025-05-01
articleOpen access
Frequent coauthors
- 106 shared
Donald I. Abrams
- 82 shared
Janice Walker
- 82 shared
Lawrence R. Crane
University of Alabama at Birmingham
- 82 shared
Roberta Luskin‐Hawk
- 82 shared
Wafaa El‐Sadr
Columbia University
- 81 shared
Chris Pulling
- 81 shared
Ann M. Labriola
Veterans Health Administration
- 81 shared
Stanley L. John
Harlem Hospital Center
Labs
Education
M.D.
University of Chicago
B.S.
University of Chicago
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Renslow Sherer
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup